Literature DB >> 3873215

Role of beta-lactam hydrolysis in the mechanism of resistance of a beta-lactamase-constitutive Enterobacter cloacae strain to expanded-spectrum beta-lactams.

H Vu, H Nikaido.   

Abstract

Enterobacter cloacae strains producing chromosomally mediated beta-lactamase constitutively show high degrees of resistance to most of the third-generation beta-lactams. It has been proposed that this resistance is due to the nonhydrolytic binding or trapping of beta-lactams by the enzyme. We found that the outer membrane of E. cloacae strain 55M indeed had permeability to cefazolin about 14-fold lower than that of Escherichia coli, and that the number of beta-lactamase molecules produced by this constitutive mutant was exceptionally large (2 X 10(5) per cell). These conditions are expected to produce a low degree of resistance, but could not explain the high resistance level of the mutant. We showed that the beta-lactamase of this strain hydrolyzed third-generation beta-lactams at measurable rates. Although the V max for these compounds was less than 0.01% of that for cefazolin, the enzyme could hydrolyze them at rates comparable to the rate for cefazolin when the substrate concentration was near 0.1 microM, a concentration thought to be physiologically relevant for the inhibition of cell growth, because of the exceptionally high affinity of the enzyme to many third-generation compounds. Calculations based on kinetic parameters of the enzyme, outer membrane permeability, and affinity toward penicillin-binding proteins succeeded in predicting the MICs for several third-generation beta-lactams. The data suggest that hydrolysis may be more important than nonhydrolytic binding for the expression of the resistant phenotype, and that studies on the susceptibility of beta-lactams to beta-lactamases should be carried out at physiologically relevant, very low concentrations of the drug, rather than the customary very high concentrations, such as 100 microM.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3873215      PMCID: PMC176283          DOI: 10.1128/AAC.27.3.393

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  [Not Available].

Authors:  G N COHEN; H V RICKENBERG
Journal:  Ann Inst Pasteur (Paris)       Date:  1956-11

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Pole cap formation in Escherichia coli following induction of the maltose-binding protein.

Authors:  I Dietzel; V Kolb; W Boos
Journal:  Arch Microbiol       Date:  1978-08-01       Impact factor: 2.552

4.  The release of enzymes by osmotic shock from Escherichia coli in exponential phase.

Authors:  N G Nossal; L A Heppel
Journal:  J Biol Chem       Date:  1966-07-10       Impact factor: 5.157

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Purification and characterization of two kinds of porins from the Enterobacter cloacae outer membrane.

Authors:  M Kaneko; A Yamaguchi; T Sawai
Journal:  J Bacteriol       Date:  1984-06       Impact factor: 3.490

7.  Novel resistance selected by the new expanded-spectrum cephalosporins: a concern.

Authors:  C C Sanders
Journal:  J Infect Dis       Date:  1983-03       Impact factor: 5.226

8.  Diffusion of beta-lactam antibiotics through the porin channels of Escherichia coli K-12.

Authors:  F Yoshimura; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1985-01       Impact factor: 5.191

9.  Function of the outer membrane of Escherichia coli as a permeability barrier to beta-lactam antibiotics.

Authors:  W Zimmermann; A Rosselet
Journal:  Antimicrob Agents Chemother       Date:  1977-09       Impact factor: 5.191

10.  Kinetics and significance of the activity of the Sabath and Abrahams' beta-lactamase of Pseudomonas aeruginosa against cefotaxime and cefsulodin.

Authors:  D M Livermore
Journal:  J Antimicrob Chemother       Date:  1983-02       Impact factor: 5.790

View more
  86 in total

Review 1.  Impact of antimicrobial agents and chemotherapy from 1972 to 1998.

Authors:  M N Swartz
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

Review 2.  Molecular basis of bacterial outer membrane permeability revisited.

Authors:  Hiroshi Nikaido
Journal:  Microbiol Mol Biol Rev       Date:  2003-12       Impact factor: 11.056

3.  Purification of Staphylococcus aureus beta-lactamases by using sequential cation-exchange and affinity chromatography.

Authors:  D S Kernodle; D J Zygmunt; P A McGraw; J R Chipley
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

Review 4.  Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 2.

Authors:  G L Drusano; William Hope; Alasdair MacGowan; Arnold Louie
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

Review 5.  Resistance to third generation cephalosporins: the current situation.

Authors:  J C Pechère
Journal:  Infection       Date:  1989 Sep-Oct       Impact factor: 3.553

6.  Preferential hydrolysis of cis configuration compounds at the 3,4 position of monobactams by beta-lactamase from Morganella morganii.

Authors:  K Matsuda; M Sanada; S Nakagawa; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

7.  Lack of additive effect between mechanisms of resistance to carbapenems and other beta-lactam agents in Pseudomonas aeruginosa.

Authors:  C Dib; J Trias; V Jarlier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-11       Impact factor: 3.267

8.  A survey of the kinetic parameters of class C beta-lactamases. Penicillins.

Authors:  M Galleni; J M Frère
Journal:  Biochem J       Date:  1988-10-01       Impact factor: 3.857

Review 9.  Multidrug resistance in bacteria.

Authors:  Hiroshi Nikaido
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

10.  Multidrug efflux pump AcrAB of Salmonella typhimurium excretes only those beta-lactam antibiotics containing lipophilic side chains.

Authors:  H Nikaido; M Basina; V Nguyen; E Y Rosenberg
Journal:  J Bacteriol       Date:  1998-09       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.